重症患者纤维蛋白原缺乏症的现代诊疗观点  

Fibrinogen deficiency in critical ill patients:Current perspectives

作　　者：宋景春[1] SONG Jing-chun(Intensive Care Unit,the 94th Hospital of PLA,Nanchang 330002,Jiangxi,China)

机构地区：[1]解放军第九四医院重症医学科,南昌330002

出　　处：《东南国防医药》2018年第5期454-458,共5页Military Medical Journal of Southeast China

摘　　要：纤维蛋白原缺乏症是危重症患者经常出现的凝血疾病。该疾病病因众多,机制复杂,临床既可表现为血栓,又可表现为出血,不易明确诊断。一旦治疗不及时,就容易造成不良预后。文章主要对危重患者纤维蛋白原缺乏症的分型、病理生理、诊断方法和治疗要点进行评述。Critically ill patients often suffered fibrinogen de ciency. The disease has numerous etiologies and complicated mechanisms. The clinical features were manifested as thrombosis or hemorrhage, which made clinical diagnosis difficult and were easily to cause death. This article briefly describes the classification, pathophysiology, diagnosis and treatment of fibrinogen de ciency in critically ill patients.

关 键 词：纤维蛋白原 异常 重症 遗传性 获得性 

分 类 号：R591.2[医药卫生—内科学]